Agent Responsible For Protection Against Early Stages Of Atherosclerosis Identified

Researchers from Boston University School of Medicine (BUSM) have identified for the first time the A2b adenosine receptor (A2bAR) as a possible new therapeutic target against atherosclerosis resulting from a diet high in fat and cholesterol.

See the article here:
Agent Responsible For Protection Against Early Stages Of Atherosclerosis Identified

Leave a Reply